Table 5 Impact of clinical events on EQ-5D_Index among AVR patients accounting for time-to-death

Value at baseline

0.348^***

0.346^***

0.333^***

0.331^***

0.333^***

0.331^***

ASB life threatening/disabling

−0.0593

−0.140^*

0.0356

−0.0497

−0.0599

−0.121

…at the second follow-up after event

−0.145^*

−0.155^*

−0.0993

…at the third follow-up after event

−0.163^**

−0.0950

−0.145^*

NASB life threatening/disabling

−0.449^***

−0.493^***

−0.457^***

−0.508^***

−0.448^***

−0.465^***

…at the second follow-up after event

−0.114

−0.140

−0.101

…at the third follow-up after event

0.103

0.0936

0.109

Stroke / TIA

−0.147^*

−0.206^**

−0.145^*

−0.210^**

−0.147^*

−0.199^*

…at the second follow-up after event

−0.123

−0.146^*

−0.121

…at the third follow-up after event

−0.0319

−0.0286

−0.0307

AKIN 2

−0.167^*

−0.226^**

−0.267^**

−0.270^**

−0.169^*

−0.272^**

…at the second follow-up after event

−0.142

−0.0428

−0.195^*

…at the third follow-up after event

0.0657

0.0150

0.0508

AKIN 3

−0.173^**

−0.186^**

−0.235^**

−0.293^***

−0.381^***

−0.418^***

…at the second follow-up after event

−0.113

−0.177^*

−0.235^**

…at the third follow-up after event

−0.00684

−0.0338

−0.0939

Other complications

0.00548

0.00571

0.0134

0.0140

0.00464

0.00368

Last follow-up before death

−0.493^***

−0.487^***

Second last follow-up before death

−0.275^***

−0.272^***

Third from last follow-up before death

−0.210^***

−0.217^***

Fourth from last follow-up before death

−0.180^***

−0.189^***

Fifth from last follow-up before death

−0.154^***

−0.166^***

Sixth from last follow-up before death

−0.108^**

−0.116^**

Overall trend

−0.00161

−0.00222^**

−0.00195^*

−0.00249^**

−0.00322^***

−0.00386^***

Month 1 post-discharge

−0.0230

−0.0283

−0.0256

−0.0301

−0.0163

−0.0218

Constant

0.529^***

0.543^***

0.548^***

0.559^***

0.508^***

0.523^***

N

2212

2212

2102

2102

2250

2250